Priya Singhal
Equibles does not estimate personal net worth.
Get an email with a short summary when Larimar Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get LRMR alertsAbout Priya Singhal
The proxy statement of Larimar Therapeutics, Inc. reports total compensation of $1,398,665 for Priya Singhal in fiscal 2019, including a base salary of $360,852. Larimar Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Larimar Therapeutics, Inc. includes Carole Ben-Maimon (CEO and Board Member), Carole S. Ben-Maimon (CEO and Board Member), Joseph Truitt (Chairman and Board Member) and 7 others.
Affiliation history
-
Larimar Therapeutics, Inc. (LRMR)
Proxy statement
Current
Company network
Leadership on record at Larimar Therapeutics, Inc.
- Carole Ben-Maimon CEO, Board Member
- Carole S. Ben-Maimon CEO, Board Member
- Joseph Truitt Chairman, Board Member
- Michael Celano CFO
- John B. Harlow, Jr. COO
- Frank E. Thomas Board Member
- Jeffrey W. Sherman, MD, FACP Board Member
- Jonathan Leff Board Member
- Thomas E. Hamilton Board Member
- Thomas Edward Hamilton Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2019 | Larimar Therapeutics, Inc. (LRMR) | Former Head of Research & Development | $360,852 | $1,398,665 |
Recent activity
No call appearances or filed executive changes recorded yet.